You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novo
since
auto-detected in 133 stories
2 hours ago
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
4 days ago
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India ○
found
a story from CNBC ⚠️ › World News
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
6 days ago
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment ⊖
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
11 days ago
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison ○
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
13 days ago
Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator ⊕
The new recommendation will significantly expand access to Wegovy on the England's NHS.
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly ⊕
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
20 days ago
Fat jabs for £10 a MONTH? Indian drug companies launch cheaper GLP-1s to rival Wegovy and Ozempic ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
Novo Nordisk's exclusive hold on semaglutide - the active ingredient in popular fat-busting GLP-1 jabs such as Wegovy and Ozempic - expired last Friday.
35 days ago
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs ⊖
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
42 days ago
Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly ○
found
Novo Nordisk is investing in a facility in Ireland as it expands its production capacities of the newly launched Wegovy pill, the Danish drugmaker said Monday.
47 days ago
These 4 charts show the scale of Novo Nordisk's woes ⊖
Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market.